^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Labcorp® Plasma Focus™

    Company:
    LabCorp
    Type:
    FDA Approved
    Related tests:

    Details

    Evidence
    News
    Labcorp® Plasma Focus™ is a highly actionable liquid biopsy test with a clear report that focuses on FDA-approved and guideline-driven biomarkers for patients with advanced solid cancers. Simplifies tumor genomic profiling process with a convenient blood draw that can reflex from tissue testing and delivers clear results. Delivers personalized results for patients’ unique tumors within 7-10 days.
    Cancer:
    Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Melanoma, Non Small Cell Lung Cancer
    Gene:
    ALK (Anaplastic lymphoma kinase), CCND1 (Cyclin D1), EGFR (Epidermal growth factor receptor), FGFR2 (Fibroblast growth factor receptor 2), HER-2 (Human epidermal growth factor receptor 2), KIT (KIT proto-oncogene, receptor tyrosine kinase)
    See More ...
    Method:
    Liquid biopsy
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    08/02/24
    ST
    -
    FDA